Stockreport

Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates

Rallybio Corporation  (RLYB) 
PDF – RLYB116 Confirmatory PK/PD Study Data Expected in 4Q 2025 –– Generated $20 Million from Sale of Interest in REV102 –– Cash Runway Extended through 2027 – NEW HAVEN, [Read more]